authors
- Ruan, Jia
- Leonard, John P
- Martin, Peter
- Coleman, Morton
- Furman, Richard R
- Cheung, Ken
- Adam Faye MD MS
- Elstrom, Rebecca
- Lachs, Mark
- Hajjar, Katherine A
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2010
published in
- Cancer Journal
has subject area
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols
- Cyclophosphamide
- Etoposide
- Female
- Humans
- Lymphoma, Mantle-Cell
- Male
- Middle Aged
- Neovascularization, Pathologic
- Prednisone
- Procarbazine
- Quality of Life
- Recurrence
- Rituximab
- Thalidomide
- Treatment Outcome